Quick Order Cart

Cat. No. ARG42592

CAT Knockout Hela Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Uterus (cervix)

  • Disease:

    Adenocarcinoma

The CAT Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal cell population derived from human HeLa cervical adenocarcinoma cells, engineered to disrupt the catalase gene. This knockout model abolishes the primary enzymatic defense against hydrogen peroxide, leading to elevated oxidative stress. Catalase is transcriptionally regulated by NFE2L2 (Nrf2) and FOXO3, and functionally interacts with SOD1 and GPX1, integrating into the cellular antioxidant network. This model is ideal for studying redox signaling, cancer cell adaptation, and oxidative stress-related pathologies such as acatalasemia, diabetes mellitus, and vitiligo. Key experimental applications include ROS quantification, H2O2 challenge viability assays, lipid peroxidation measurement, and apoptosis analysis, supporting research into drug resistance and senescence.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HeLa

    Sex of Donor

    Female

    Age

    31 years

    Gene Name

    CAT

    Gene Identifier

    NCBI Gene ID 847

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The CAT Knockout HeLa Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population engineered to disrupt the CAT gene in the human HeLa cell line. This loss-of-function model eliminates catalase expression, the primary enzyme responsible for decomposing hydrogen peroxide into water and oxygen. The heterogeneous population provides a physiologically relevant system for studying oxidative stress responses without clonal selection artifacts, enabling robust analysis of hydrogen peroxide-mediated signaling pathways and antioxidant defense mechanisms.

HeLa cells are a widely utilized human epithelial cell line derived from a cervical adenocarcinoma, known for their HPV18-positive status and robust growth characteristics. As a model of cancer cell biology, HeLa cells exhibit altered redox homeostasis, making them particularly suitable for investigating the consequences of catalase deficiency. This host background facilitates the examination of oxidative stress in a transformed cellular environment, where reactive oxygen species (ROS) play critical roles in proliferation, apoptosis, and therapeutic resistance.

Catalase functions downstream of key oxidative stress regulators including the transcription factor NFE2L2 (Nrf2), FOXO3, PPARG, and HIF1A, and its expression is modulated by stimuli such as hydrogen peroxide and TNF-??. In the knockout context, loss of CAT disrupts hydrogen peroxide catabolism, leading to accumulation of intracellular H2O2. This elevates oxidative stress, promoting protein carbonylation and lipid peroxidation, and activates redox-sensitive cascades like MAPK and NF-??B. Catalase collaborates with SOD1, GPX1, and PRDX1, and requires PEX5 for peroxisomal import, integrating into a network where SOD1 converts superoxide to H2O2, which is then detoxified by CAT or GPX1, with NFE2L2 serving as a master regulator through KEAP1-mediated sensing.

In the HeLa cancer cell model, CAT knockout accentuates the intrinsic oxidative burden, providing a powerful tool to study tumor cell adaptation to oxidative microenvironments. Elevated hydrogen peroxide levels can drive genomic instability, modulate proliferation, and influence sensitivity to chemotherapeutic agents. This model is particularly relevant for research into acatalasemia, diabetes mellitus, vitiligo, and cancer, where catalase dysfunction or oxidative stress plays a pathogenic role. By uncoupling antioxidant capacity, researchers can dissect the contribution of catalase to cellular survival under pathophysiological conditions.

Researchers can employ this knockout model for diverse applications including quantitative H2O2 measurement via Amplex Red, ROS detection with DCFDA, and catalase activity assays to confirm disruption. Viability assays under hydrogen peroxide challenge, lipid peroxidation assessment by TBARS, DNA damage analysis using comet assays, and apoptosis detection with Annexin V staining enable mechanistic studies of oxidative stress responses. Transcriptome-wide RNA-seq and targeted gene expression analysis by RT-qPCR further elucidate redox-sensitive transcriptional programs. This model is instrumental for investigations into drug resistance, cellular senescence, and antioxidant defense. For additional information or to discuss your specific research needs, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)